As part of a phase 1 clinical trial of a variant-specific COVID-19 vaccine developed by Moderna, pharmacist Sue Lasicka gives a shot of the vaccine candidate to volunteer Suzanne Uvelli-Spencer, MD, on April 1, 2021, at Kaiser Permanente Washington Health Research Institute in Seattle. Credit: Courtesy of Jonathan Rabinovitz
Seattle-based clinical trial tweaks mRNA vaccines to fight Covid variants Apr 08, 2021
Researchers are testing a new Covid-19 vaccine. Part of the clinical trial is taking place here in Seattle. The trial will tweak the Moderna vaccine to fight one variant of the Covid virus, B1351. That s the variant first discovered in South Africa.
This interview has been edited for clarity.